Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyclovir 5% lipstick for recurrent herpes labialis
2011-002135-26Phase 3Completed
- Sponsor
- Aesculapius Farmaceutici
- Start
- Dec 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in herpes labialis and herpes simplex (HSV) comparing Acyclovir 5% lipstick with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Dec 2011; status: completed.
02
Drugs
aciclovir
03
Conditions
herpes labialisherpes simplex (HSV)
Beyond the preview
Go deeper on 2011-002135-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002135-26.